Light conditions for behavioural assays. Day phase length included the three-hour transitions at lights on/off, except under constant conditions (LL and DD). by Charlotte N. Underwood (5043110)

Subjects:

Changepoint analysis in comparison of MarBTN-specific eDNA and cancer in hemolymph. by Rachael M. Giersch (22331947)

Subjects:

Distribution of the amount of physical activity recorded during head-raising movements. by Akihiro Ohnishi (10989900)

Subjects:

Comparison of the studied complete blood count parameters between <i>Anaplasma</i> spp. and <i>A. ovis</i> positive and negative goats enrolled from Dera Ghazi Khan district in Pun... by Sumaira Sumaira (21453523)

Subjects:

Biweekly Changes in Body Weight, Body Fat Percentage, Muscle Mass, and BMI During the Retraining Period. by Burhan Demirkıran (21601740)

Subjects:

Survival of soft-shell clams with MarBTN compared to control clams. by Rachael M. Giersch (22331947)

Subjects:

Introduction to the dataset. by Dequan Wang (6007007)

Subjects:

Egg-induced IL-1β and IL-17 production is dependent on both Caspase-1 and Caspase-8. by Madhusoodhanan Suresh Kumar Meena Kumari (20896666)

Subjects:

Chromatograms proved the selectivity of the proposed method. Red line: tissue spiked at the LOQ level; green line: blank tissue. Panel A: SIM and SIMA; panel B: LOV and LOVA. by Ewa Paszkowska (21246702)

Subjects:

Comparison of postoperative rest and activity between APS score groups in Experiment 2. by Akihiro Ohnishi (10989900)

Subjects:

Phylogenetic analysis of <i>Anaplasma</i> spp. based on the partial 16S rRNA gene sequence. by Sumaira Sumaira (21453523)

Subjects:

Analysis of correlation between hub genes and immune cells. by Wei He (131453)

Subjects:

Downregulation of miR-1247-3p inhibited apoptosis and reduced chemosensitivity in cells. by Dequan Wang (6007007)

Subjects:

Spatial and temporal variation of the mean abundance of coral recruits at the 10 stations located on the three major habitats, for the five categories (all taxa pooled, Acroporidae... by Radonirina Lebely Botosoamananto (13989736)

Subjects:

miR-1247-3p was downregulated in tissues of patients with CRC and was associated with prognosis and drug resistance. by Dequan Wang (6007007)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Among them, <b>E35</b> demonstrated excellent inhibitory activities against the binding of Skp2–Cks1. In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Among them, <b>E35</b> demonstrated excellent inhibitory activities against the binding of Skp2–Cks1. In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Among them, <b>E35</b> demonstrated excellent inhibitory activities against the binding of Skp2–Cks1. In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Among them, <b>E35</b> demonstrated excellent inhibitory activities against the binding of Skp2–Cks1. In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Among them, <b>E35</b> demonstrated excellent inhibitory activities against the binding of Skp2–Cks1. In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”